Is complete mesocolic excision or total mesorectal excision necessary during cytoreductive surgery in ovarian peritoneal carcinomatosis with colonic involvement?

References

• Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol. 1988;19(1):57–63.
   PubMed Web of Science ®Google Scholar
• Rose PG, Piver MS, Tsukada Y, et al. Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer. 1989;64(7):1508–1513.
   PubMed Web of Science ®Google Scholar
• Chua TC, Robertson G, Liauw W, et al. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results. J Cancer Res Clin Oncol. 2009;135(12):1637–1645.
   PubMed Web of Science ®Google Scholar
• Di Giorgio A, Naticchioni E, Biacchi D, et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer. 2008;113(2):315–325.
   PubMed Web of Science ®Google Scholar
• Helm CW, Richard SD, Pan J, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer. 2010;20(1):61–69.
   PubMed Web of Science ®Google Scholar
• Huo YR, Richards A, Liauw W, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2015;41(12):1578–1589.
   PubMed Web of Science ®Google Scholar
• Karadayi K, Turan M, Karadayi S, et al. Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy: morbidity and mortality analysis of our patients. Turkiye Klinikleri J Med Sci. 2012;32(1):162–170.
   Google Scholar
• Karadayi K, Yildiz C, Karakus S, et al. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for gynecological malignancies: a single center experience. Eur J Gynaecol Oncol. 2016;37(2):194–198.
   PubMed Web of Science ®Google Scholar
• Delgado G, Oram DH, Petrilli ES. Stage III epithelial ovarian cancer: the role of maximal surgical reduction. Gynecol Oncol. 1984;18(3):293–298.
   PubMed Web of Science ®Google Scholar
• Griffiths CT, Parker LM, Fuller AF. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep. 1979;63(2):235–240.
   PubMedGoogle Scholar
• Hacker NF, Berek JS, Lagasse LD, et al. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol. 1983;61(4):413–420.
   PubMed Web of Science ®Google Scholar
• Heintz AP, Hacker NF, Berek JS, et al. Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol. 1986;67(6):783–788.
   PubMed Web of Science ®Google Scholar
• Jänicke F, Hölscher M, Kuhn W, et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer. 1992;70(8):2129–2136.
   PubMed Web of Science ®Google Scholar
• Neijt JP, ten Bokkel Huinink WW, van der Burg MEL, et al. Long-term survival in ovarian cancer: Mature data from The Netherlands joint study group for ovarian cancer. Eur J Cancer Clin Oncol. 1991;27(11):1367–1372.
   Google Scholar
• Omura GA, Bundy BN, Berek JS, et al. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 1989;7(4):457–465.
   PubMed Web of Science ®Google Scholar
• Piver MS, Lele SB, Marchetti DL, et al. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol. 1988;6(6):983–989.
   PubMed Web of Science ®Google Scholar
• Vogl SE, Pagano M, Kaplan BH, et al. Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens. Cancer. 1983;51(11):2024–2030.
   PubMed Web of Science ®Google Scholar
• Hertel H, Diebolder H, Herrmann J, et al. Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol. 2001;83(3):481–484.
   PubMed Web of Science ®Google Scholar
• Hoffman MS, Griffin D, Tebes S, et al. Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management. Am J Obstet Gynecol. 2005;193(2):582–586. discussion 6–8.
   PubMed Web of Science ®Google Scholar
• Tamussino K, Lim P, Webb M, et al. Gastrointestinal surgery in patients with ovarian cancer. Gynecol Oncol. 2001;80(1):79–84.
   PubMed Web of Science ®Google Scholar
• Heald R, Husband E, Ryall R. The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg. 2005;69(10):613–616.
   Google Scholar
• Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation-technical notes and outcome. Colorectal Dis. 2009;11(4):354–364. discussion 64–65.
   PubMed Web of Science ®Google Scholar
• Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979–994.
   PubMed Web of Science ®Google Scholar
• Karadayi K, Bostanci M, Mollaoglu M, et al. Cytoreductive surgery and perioperative intraperitoneal chemotherapy experience in peritoneal carcinomatosis: single-center analysis of 180 cases. Int J Surg Oncol. 2021;2021:8851751.
   PubMed Web of Science ®Google Scholar
• Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–1482.
   PubMed Web of Science ®Google Scholar
• Baiocchi G, Cestari LA, Macedo MP, et al. Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection. J Surg Oncol. 2011;104(3):250–254.
   PubMed Web of Science ®Google Scholar
• Gallotta V, Fanfani F, Fagotti A, et al. Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations. Ann Surg Oncol. 2014;21(7):2369–2375.
   PubMed Web of Science ®Google Scholar
• Gouy S, Goetgheluck J, Uzan C, et al. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer. Eur J Surg Oncol. 2012;38(2):170–175.
   PubMed Web of Science ®Google Scholar
• Lax Petru Holzer Pertl Ralph Greenspan, et al. Mesenteric and mesocolic lymph node metastases from ovarian carcinoma: a clinicopathological analysis. Int J Gynecol Cancer. 1998;8(2):119–123.
   Web of Science ®Google Scholar
• O'Hanlan KA, Kargas S, Schreiber M, et al. Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection. Gynecol Oncol. 1995;59(2):200–206.
   PubMed Web of Science ®Google Scholar
• Salani R, Diaz-Montes T, Giuntoli RL, et al. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Ann Surg Oncol. 2007;14(12):3552–3557.
   PubMed Web of Science ®Google Scholar
• Padera T, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002;296(5574):1883–1886.
   PubMed Web of Science ®Google Scholar
• Surawicz C. Gastrointestinal pathology: an atlas and text: C. M. Fenoglio-Preiser, P. E. Lantz, M. B. Listrom, M. Davis, F. O. Rilke. New York: Raven Press, 1989, 892 pp. Price: $225.00. Accompanying set of 125 slides: $195.00. Dis Colon Rectum. 1989;32(11):1003.
   Google Scholar
• Jamieson JK, Dobson JF. The lymphatics of the colon. Proc R Soc Med. 1909;2(Surg Sect):149–174.
   PubMedGoogle Scholar
• Plentl AA, Friedman EA. Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol. 1971;2:1–223.
   PubMedGoogle Scholar
• Di Giorgio A, Cardi M, Biacchi D, et al. Depth of colorectal-wall invasion and lymph-node involvement as major outcome factors influencing surgical strategy in patients with advanced and recurrent ovarian cancer with diffuse peritoneal metastases. World J Surg Oncol. 2013;11:64.
   PubMed Web of Science ®Google Scholar
• Scarabelli C, Gallo A, Franceschi S, et al. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma. Cancer. 2000;88(2):389–397.
   PubMed Web of Science ®Google Scholar
• Gadducci A, Cosio S, Zola P, et al. The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study. Gynecol Oncol. 2010;116(3):358–363.
   PubMed Web of Science ®Google Scholar
• Santillan A, Karam AK, Li AJ, Giuntoli R, 2nd, et al. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Gynecol Oncol. 2007;104(3):686–690.
   PubMed Web of Science ®Google Scholar
• Park JY, Seo SS, Kang S, et al. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Gynecol Oncol. 2006;103(3):977–984.
   PubMed Web of Science ®Google Scholar
• Peiretti M, Bristow RE, Zapardiel I, et al. Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes. Gynecol Oncol. 2012;126(2):220–223.
   PubMed Web of Science ®Google Scholar
• Mourton SM, Temple LK, Abu-Rustum NR, et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2005;99(3):608–614.
   PubMed Web of Science ®Google Scholar
• Carlsen E, Schlichting E, Guldvog I, et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg. 1998;85(4):526–529.
   PubMed Web of Science ®Google Scholar